Constructive Bio, a trailblazer in synthetic genomics, has secured a remarkable $58 million in Series A funding, spearheading advances in biofactory technology.Established recently as a University…
Abolis Biotechnologies, a trailblazer in sustainable biotechnology, has recently secured €35 million in funding, a milestone achievement for the French startup. This significant investment round was…
